Fundraising FoxMiromatrix
Eden Prairie, US · 1 known investors
Find your way into Miromatrix
Sign up to see every warm intro you have to Miromatrix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Miromatrix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Miromatrix develops fully biologic organs using decellularization and recellularization technology for transplant patients. The company focuses on engineering transplantable kidneys, livers, and liver support devices to address the critical shortage of donor organs.
Founders & leadership
JR
Jeff RossExecutive
RC
Robert CohenNamed on SEC filing
JA
Joseph AlexanderSecretary
Board
RE
Ronald EibensteinerBoard director
TF
Timothy FlynnBoard director
WS
Walter SembrowichBoard director
TJ
Timothy J. PawlentyBoard director
Investors · 1
Funding
SEC filings, press & company announcements$39.5M disclosed across 2 of 3 rounds · 2013–2021
- Undisclosed amountIPOJun 2021Source ↗
▶$15.7MraisedJul 2018 · 55 investors · BiotechnologyRule 506(b)
▶$15.7MraisedJul 2018 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ronald EibensteinerDirector
- Mark WagnerDirector
- Paul BuckmanDirector
- Jeffrey RossExecutive Officer, Director
- John J. ErbDirector
- Brian NieburExecutive Officer
- Offering amount
- $15.7M
- Amount sold
- $15.7M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.8MraisedNov 2015 · 124 investors · BiotechnologyRule 506(b)
▶$23.8MraisedNov 2015 · 124 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy FlynnDirector
- Robert CohenExecutive Officer, Director, Promoter
- Joseph AlexanderExecutive Officer
- Jeff RossExecutive Officer
- Ronald EibensteinerDirector
- Walter SembrowichDirector
- Timothy J. PawlentyDirector
- Offering amount
- $25M
- Amount sold
- $23.8M
- Minimum investment
- $50K
- Finders' fees
- $171.3K
- Placement agents
- Van Clemens & Co., Inc., Terence J. Redmond, Woodrow L. Blevins, Mark D. Witmer, Blake Capital Partners, LLC, Valenti Synergy Consulting, LLC, Charlie Nickoloff
- First sale
- Oct 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Mirum PharmaceuticalsMirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases. It operates in the U.S. and Europe, engaging with healthcare professionals, patients, and payers within applicable regulatory frameworks.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Mereo BioPharma GroupMereo BioPharma is a biopharmaceutical company publicly traded on Nasdaq under the ticker MREO. This page presents its share price data and SEC filings for investors and commercial partners.
Epirium BioEpirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.
Companies working in the same space as Miromatrix.
In the news
Frequently asked questions
- What does Miromatrix do?
- Miromatrix develops fully biologic organs using decellularization and recellularization technology for transplant patients. The company focuses on engineering transplantable kidneys, livers, and liver support devices to address the critical shortage of donor organs.
- Who are Miromatrix's investors?
- Miromatrix's investors include Brightstone Venture Capital.
- How much funding has Miromatrix raised?
- Miromatrix has disclosed $39.5M raised across 2 of its 3 known rounds.
- Where is Miromatrix headquartered?
- Miromatrix is headquartered in Eden Prairie, US.